Evidence map›Paper›PMID 40694235›Full record

ArticlePhysical and engineering sciences in medicine2025

Evaluation of a digital bismuth germanium oxide PET/CT system according to the Japanese brain tumor phantom test for

Shohei Fukai, Hiromitsu Daisaki, Honoka Yoshida, Naoki Shimada, Kazuki Motegi, Atsushi Osawa, Takashi Terauchi

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shohei FukaiDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. syohei.fukai@jfcr.or.jp.ORCID http://orcid.org/0000-0002-2321-2984
Hiromitsu DaisakiGraduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki-Machi, Maebashi, Gunma, 371-0052, Japan.
Honoka YoshidaDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Naoki ShimadaDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Kazuki MotegiDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Atsushi OsawaDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Takashi TerauchiDepartment of Nuclear Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Omni Legend (GE Healthcare), equipped with a digital bismuth germanium oxide PET/CT system, has been recently developed. However, the performance of the Omni Legend without a time-of-flight (TOF) system for

Indexed as

BismuthBrain NeoplasmsButyratesCarboxylic AcidsCyclobutanesGermaniumPhantoms, ImagingPositron Emission Tomography Computed TomographyHumansImage Processing, Computer-AssistedJapanBismuthbismuth oxideButyratesCarboxylic AcidsCyclobutanesfluciclovine F-18Germanium18F-fluciclovineDigital BGO PETJapanese brain tumor phantom testPET/CT

Identifiers

PMID40694235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.